Avenue Therapeutics Inc.

1.01
-0.09 (-8.18%)
At close: Mar 03, 2025, 3:55 PM
0.99
-1.86%
After-hours: Mar 03, 2025, 04:44 PM EST

Avenue Therapeutics Income Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income -14.54M -8.04M -3.74M -5.21M -26.27M -21.82M -11.42M -2.38M -4.84M
Interest Income 126K 20K 7K 62K 357K 93K 88K n/a n/a
Pretax Income -10.49M -3.6M -3.73M -5.15M -25.91M -21.55M -12.26M -3.18M -5.23M
Net Income -10.38M 2.05M -3.72M -5.09M -25.55M -21.28M -12.26M -3.18M -5.23M
Selling & General & Admin 4.18M 5.34M 2.48M 2.35M 3.07M 4.12M 3.62M 997K 842K
Research & Development 10.36M 2.7M 1.25M 2.87M 23.19M 17.7M 7.8M 1.38M 4M
Other Expenses n/a n/a n/a n/a n/a 175K -99K n/a n/a
Operating Expenses 14.54M 8.04M 3.74M 5.21M 26.27M 21.82M 11.42M 2.38M 4.84M
Interest Expense n/a 1.16M n/a n/a n/a n/a 375K 612K 417.82K
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a -76.55K
Cost & Expenses 14.54M 8.04M 3.74M 5.21M 26.27M 21.82M 11.42M 2.38M 4.84M
Income Tax n/a -5.65M -7K -62K -357K -268K 287K -1.76M -5.28M
Shares Outstanding (Basic) 141K 2.19M 1.13M 1.1M 1.05M 682.61K 442.33K 589.43K 556.1K
Shares Outstanding (Diluted) 141.22K 2.19M 1.13M 1.1M 1.05M 682.61K 442.33K 589.43K 556.1K
EPS (Basic) -73.6 0.94 -3.29 -4.62 -24.38 -31.17 -27.71 -5.39 -9.4
EPS (Diluted) -73.48 0.94 -3.29 -4.62 -24.38 -31.17 -27.71 -5.39 -9.4
EBITDA 4.05M n/a n/a -5.21M n/a n/a n/a -188K 440.27K
Depreciation & Amortization 14.54M 8.04M 3.74M 5.21M 26.27M 21.82M 11.42M 2.38M 5.28M